Cite
MLA Citation
H. Lee et al.. “P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 STUDY (SGN35 027 PART B).” HemaSphere, vol. 6, n.d., pp. 979–980. http://access.bl.uk/ark:/81055/vdc_100159756595.0x000006